Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MNA ANALYSIS: Cardio And Ortho Billion-Buck Deals Headline Otherwise Slow Month

This article was originally published in Clinica

Executive Summary

The medtech industry saw few mergers or acquisitions in June, but the summer slowdown included some noteworthy deals that could shake-up their respective industries.

You may also be interested in...



Earnings Winners And Losers: BSX, BCR, NUVA, NVCR

Several big names in medtech announced their second-quarter sales and earnings in late July and early August. Here are some of the companies that impressed investors and others that raised some doubts.

Zimmer Biomet Mirrors Medtronic's Robotics Move With Medtech SA

Zimmer Biomet will gain through a $130m deal a spine-surgery robot that may be able to compete in the emerging minimally invasive spine surgery segment. The technology will also complement Zimmer Biomet’s other recent acquisition in spine surgery devices.

New Approaches To AF Ablation And Mapping

The market for atrial fibrillation catheter ablation devices continues to grow even as the field wrestles with basic questions and as new study results may dampen enthusiasm for some technologies. Though strategics dominate this sector, innovators with new approaches to ablation and mapping hope to help resolve unknowns and take a piece of this vast and underpenetrated market.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT103565

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel